Achaogen (AKAO) News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period February 21, 2024 | benzinga.comRavi Viswanathan's Net WorthDecember 28, 2023 | bbc.comCOP28: Climate mums make themselves heard in halls of powerOctober 25, 2023 | investing.comAKAOQ Historical DataJuly 28, 2022 | finance.yahoo.comSepterna Strengthens Leadership Team to Advance Novel Small Molecule GPCR Medicines - Yahoo FinanceJune 13, 2022 | nj.comAn N.J. medical expert warns of the rise of superbugs | Opinion - NJ.comApril 28, 2022 | streetinsider.comFlare Therapeutics Appoints Adrian Jubb as Chief Medical Officer - StreetInsider.comApril 26, 2022 | finance.yahoo.comFlare Therapeutics Appoints Adrian Jubb as Chief Medical Officer - Yahoo FinanceApril 13, 2022 | law360.comCipla Calls Achaogen Claims Over Lost Ch. 11 Sales 'Weak' - Law360April 13, 2022 | ft.comGreater access to antibiotics is essential for curbing drug resistance - Financial TimesApril 4, 2022 | bizjournals.comLife sciences VC 5AM Ventures adds 2 new funds totaling $750M - San Francisco Business Times - The Business JournalsMarch 19, 2022 | thetimes.co.ukShortage of new antibiotics stokes fears of a 'silent pandemic' - The TimesFebruary 14, 2022 | forbes.comForever In Love And In Love With Forever: Introducing The World's First True Longevity Couple - ForbesFebruary 2, 2022 | globenewswire.comGlobal Urinary Tract Infection Therapeutics Market Size Will Touch USD 11652 Million Mark by 2027, at a 4.56% CAGR - GlobeNewswireJanuary 27, 2022 | finance.yahoo.comApplied Molecular Transport Announces Board Appointments - Yahoo FinanceNovember 25, 2021 | fortune.comTo avoid the superbug pandemic, we must fix the business model for new antibiotics - FortuneNovember 4, 2021 | businesswire.comGlobal Antibiotic Resistance Markets, 2019-2020 & 2021-2027 - Focus on Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies - ResearchAndMarkets.com - Business WireOctober 8, 2021 | law360.comThe Top In-House Hires Of September - Law360September 27, 2021 | businesswire.comGlobal $13.8 Billion Antimicrobial Resistance Market, 2027 | Opportunity Breakdown by Disease, Pathogen, Drug Class, End-user and Region - ResearchAndMarkets.com - Business WireSeptember 16, 2021 | prnewswire.comGlobal Antibody Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021 - PRNewswireSeptember 15, 2021 | seekingalpha.comContraFect: Non-Antibiotic Alternative That Could Disrupt The Antibiotic Market - Seeking AlphaSeptember 9, 2021 | law360.comCRISPR Biotech Co. Mammoth Hires Sangamo Atty As GC - Law360August 26, 2021 | bizjournals.comBiotech Dice led by Kevin Judice rolls toward $100M IPO - San Francisco Business Times - San Francisco Business TimesAugust 9, 2021 | businesswire.comCarbapenem-Resistant Enterobacteriaceae Infection Market Insight, Epidemiology and Market Forecast Report 2021-2030 - ResearchAndMarkets.com - Business Wire Get Achaogen News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAO and its competitors with MarketBeat's FREE daily newsletter. Email Address Top Stock Unveiled! (Ad)Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. Get Your Free Report AKAO Media Mentions By Week AKAO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKAO News Sentiment▼0.000.62▲Average Medical News Sentiment AKAO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKAO Articles This Week▼00▲AKAO Articles Average Week Get Achaogen News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bolt Biotherapeutics News Acasti Pharma News NanoViricides News NRx Pharmaceuticals News Bullfrog AI News Biora Therapeutics News Unity Biotechnology News MEI Pharma News Cocrystal Pharma News BioVie News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKAO) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achaogen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achaogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
